Iambic Therapeutics raised $100M Series B venture round, led by Kurt von Emster.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
Ascenta CapitalLEAD | Venture Capital | — |
AbingworthLEAD | Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Corporate Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Bill Rastetter |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$250M
Top Valuation
-
Iambic Therapeutics raised $100M in a Series B round.
The round was announced on 10/03/23.
The round was led by Kurt von Emster, Evan Rachlin.